Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, has appointed John Gu as its new ...
The partnership combines AbTis' AbClick site-selective conjugation platform with WuXi XDC's all-in-one development and ...
RealClearInvestigations on MSN3d
Waste of the Day: U.S. Funding Continues Dog Experiments in ChinaTopline: A Chinese lab is continuing to receive funds from the U.S. to conduct cruel studies on beagles, according to ...
WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, ...
U.S. cellular starting materials Market Size was valued at USD 0.68 Billion in 2024 and is expected to reach USD 4.45 Billion by 2034 growing at a CAGR of 20.4%.
What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing position in the biotechnology race with China has broader implications than just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback